Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MacroGenics Inc

+ Add to Watchlist

MGNX:US

31.5000 USD 0.3700 1.19%

As of 20:10:00 ET on 05/22/2015.

Snapshot for MacroGenics Inc (MGNX)

Open: 31.1600 Day's Range: 30.9750 - 31.9000 Volume: 141,282
Previous Close: 31.1300 52wk Range: 17.3100 - 39.9000 1-Yr Rtn: +69.99%

Stock Chart for MGNX

No chart data available.
  • MGNX:US 31.5000
  • 1D
  • 1M
  • 1Y
31.1300
Interactive MGNX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MGNX

Current P/E Ratio (ttm) 225.0000
Estimated P/E(12/2015) 370.5882
Relative P/E vs. SPX 11.9767
Earnings Per Share (USD) (ttm) 0.1400
Est. EPS (USD) (12/2015) 0.0850
Est. PEG Ratio -
Market Cap (M USD) 946.50
Shares Outstanding (M) 30.05
30 Day Average Volume 211,604
Price/Book (mrq) 4.0944
Price/Sale (ttm) 8.7126
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MGNX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MGNX

MacroGenics, Inc. develops novel biologics. The Company specializes in treatments for autoimmune disorders, cancer, and infectious diseases. MacroGenics serves the healthcare industry in the United States.

Scott KoenigPresident/CEO/Co-FounderJames Karrels "Jim"Senior VP/CFO/Secretary
Atul SaranSenior VP/General CounselJon WiggintonSenior VP:Clinical Dev/Mng Dir
More Company Profile & Key Executives for MGNX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil